Thomas Ly has extensive experience in biostatistics, currently serving as Senior Director of Biostatistics at Recursion. Prior roles include Director of Biostatistics at Bristol Myers Squibb and Director of Biostatistics, Head of Hematological Malignancies at Fate Therapeutics Inc. Additionally, Thomas held the position of Associate Director of Biostatistics in Late-Stage Development at Heron Therapeutics, Inc., and also served as Sr. Manager of Biostatistics at Xencor.
This person is not in the org chart
This person is not in any teams
This person is not in any offices